IHE invests in U.S. pharmaceutical stocks. Based on consensus forward earnings growth estimates, IHE looks undervalued. A high IRR is possible, especially if the portfolio's long-term earnings ...
IHE tracks the Dow Jones U.S. Select Pharmaceuticals Total Return Index, which invests solely in U.S. pharmaceutical companies. The fund is top-heavy, investing around 40% in just two companies: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results